Antibody modeling assessment

Proteins: Structure, Function and Bioinformatics

Volumn 79, Issue 11, 2011, Pages 3050-3066

  Almagro, Juan C ^a   Beavers, Mary Pat ^a   Hernandez Guzman, Francisco ^b   Maier, Johannes ^c   Shaulsky, Jodi ^b   Butenhof, Kenneth ^b   Labute, Paul ^c   Thorsteinson, Nels ^c   Kelly, Kenneth ^c   Teplyakov, Alexey ^a   Luo, Jinquan ^a   Sweet, Raymond ^a   Gilliland, Gary L ^a  

^a CENTOCOR INC   (United States)

^b ACCELRYS INC   (United States)

^c INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

Antigen binding site; Canonical structures; Homology modeling; Immunoglobulin; X ray structure

Indexed keywords

ANTIBODY;

ANTIBODY COMBINING SITE; ANTIBODY STRUCTURE; ARTICLE; CRYSTAL STRUCTURE; HUMAN; INTERNET; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; QUALITY CONTROL; SEQUENCE HOMOLOGY; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BINDING SITES, ANTIBODY; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; RATS; SEQUENCE ALIGNMENT; SOFTWARE;

EID: 80054001999     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.23130     Document Type: Article

References (35)

1. Moult J, Fidelis K, Kryshtafovych A, Rost B, Tramontano A. Critical assessment of methods of protein structure prediction-Round VIII. Proteins 2009; 77( Suppl 9): 1-4.
2. Kabat EA, Wu TT. Construction of a three-dimensional model of the polypeptide backbone of the variable region of kappa immunoglobulin light chains. Proc Natl Acad Sci USA 1972; 69: 960-964.
3. Amzel L, Poljak R. Three-dimensional structure of immunoglobulins. Annu Rev Biochem 1979; 48: 961-997.
4. Wu TT, Kabat EA. An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J Exp Med 1970; 132: 211-250.
5. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data Bank. Nucleic Acids Res 2000; 28: 235-242.
6. Morea V, Lesk AM, Tramontano A. Antibody modeling: implications for engineering and design. Methods 2000; 20: 267-279.
7. Chothia C, Lesk AM. Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 1987; 196: 901-917.
8. Chothia C, Lesk AM, Tramontano A, Levitt M, Smith-Gill SJ, Air G, Sheriff S, Padlan EA, Davies D, Tulip WR, Colman PM, Spinelli S, Alzari PM, Poljak RJ. Conformations of immunoglobulin hypervariable regions. Nature 1989; 342: 877-883.
9. Martin AC, Thornton JM. Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies. J Mol Biol 1996; 263: 800-815.
10. Al-Lazikani B, Lesk AM, Chothia C. Standard conformations for the canonical structures of immunoglobulins. J Mol Biol 1997; 273: 927-948.
11. Whitelegg NR, Rees AR. Antibody variable regions: toward a unified modeling method. Methods Mol Biol 2004; 248: 51-91.
12. Kuroda D, Shirai H, Kobori M, Nakamura H. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface. Proteins 2009; 75: 139-146.
13. North B, Lehmann ARLD, Jr. A new clustering of antibody CDR loop conformations. J Mol Biol 2011 406: 228-256.
14. Whitelegg NR, Rees AR. WAM: an improved algorithm for modelling antibodies on the WEB. Protein Eng Des Sel 2000; 13: 819-824.
15. Shirai H, Kidera A, Nakamura H. H3-rules: identification of CDR-H3 structures in antibodies. FEBS Lett 1999 455: 188-197.
16. Kuroda D, Shirai H, Kobori M, Nakamura H. Structural classification of CDR-H3 revisited: a lesson in antibody modeling. Proteins 2008 73: 608-620.
17. Zemlin M, Klinger M, Link J, Zemlin C, Bauer K, Engler JA, Schroeder HW, Kirkham PM. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol 2003; 334: 733-749.
18. James LC, Roversi P, Tawfik DS. Antibody multispecificity mediated by conformational diversity. Science 2003; 299: 1362-1367.
19. Reichert JM. Metrics for antibody therapeutics development. MAbs 2010; 695-700.
20. Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 2010; 9: 767-774.
21. Marcatili P, Rosi A, A. Tramontano. PIGS: automatic prediction of antibody structures. Bioinformatics 2008; 24: 1953-1954.
22. Sircar A, Kim ET, Gray JJ. RosettaAntibody: antibody variable region homology modeling server. Nucleic Acids Res 2009 37(Web Server issue): W474-479.
23. Sivasubramanian A, Sircar A, Chaudhury S, Gray JJ. Toward high-resolution homology modeling of antibody Fv regions and application to antibody-antigen docking. Proteins 2009; 74: 497-514.
24. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993; 234: 779-815.
25. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. CHARMM: a program for macromolecular energy. minimization, and dynamics calculations. J Comp Chem 1983; 4: 187-217.
26. Spassov VZ, Flook PK, Yan L. LOOPER: a molecular mechanics-based algorithm for protein loop prediction. Protein Eng 2008; 21: 91-100.
27. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of proteins of immunological interest, 5th ed. Washington. D.C.: Public Health Service. N.I.H.; 1991.
28. Wang J, Cieplak P, Kollman PA. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J Comput Chem 2000; 21: 1049-1074.
29. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993; 234: 779-815.
30. Kryshtafovych A, Venclovas C, Fidelis K, Moult J. Progress over the first decade of CASP experiments. Proteins: Struct Funct Bioinformatics 2005; 61( Suppl 7): 225-236.
31. Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 2010; 66: 12-21.
32. Keedy DA, Williams CJ, Headd JJ, Arendall WBr, Chen VB, Kapral GJ, Gillespie RA, Block JN, Zemla A, Richardson DC, Richardson JS. The other 90% of the protein: assessment beyond the Calphas for CASP8 template-based and high-accuracy models. Proteins 2009; 77( Suppl 9): 29-49.
33. Tramontano A, Chothia C, Lesk AM. Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins. J Mol Biol 1990; 215: 175-182.
34. Capra JD, Kehoe M. Variable region sequences of five human immunoglobulim heavy chains of the VHTTI subgroup: definitive identification of four heavy chain hypervariable regions (myeloma proteins/amino acid sequences/antibody combining site). Proc Nat Acad Sci USA 1974; 71: 845-848.
35. DeLano WL. The PyMOL molecular graphics system. Palo Alto, CA: DeLano Scientific; 2009.